News
Lifezoom, a pioneer of red light therapy in the USA, is excited to expand with the new industry-leading Veyra Series, red ...
Clarity Pharmaceuticals (ASX: CU6) ('Clarity' or 'Company'), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for ...
A specially engineered antibody that can accurately deliver RNA treatments into hard-to-reach and hard-to-treat tumors significantly improved survival and reduced tumor sizes in animal models, ...
Pimple patches have helped make acne ‘acceptable’ and added the fun into functionality, but now the format is expanding to ...
The integration of microfluidics and nanotechnology has revolutionized the landscape of cancer research, offering ...
4h
Vietnam Investment Review on MSNNature Medicine Publishes Innovent s Promising Phase 1 Gastric Cancer DataInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, ...
Iovance Biotherapeutics’ Amtagvi study data shows 49 per cent response rate for commercialisation: San Carlos, California Thursday, July 17, 2025, 12:00 Hrs [IST] Iovance Biothe ...
I tried Pelvic Floor’s single stretch routine and here’s my Review on leaks, core strength, and back‑pain relief.
Scientists identified a nuclear mechanism that distinguishes chronic inflammation from acute inflammation in mice.
Oncology biotech Prescient Therapeutics (ASX: PTX) has announced the completion of its first US site visit for its Phase 2a ...
A study published by Caris showed that certain tumor types had very low or no HER2 overexpression, which has implications for biomarker testing strategies.
Zenith Epigenetics' ZEN-3694 gains FDA fast track designation, offering hope for patients with aggressive NUT carcinoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results